145 related articles for article (PubMed ID: 22146742)
1. Immunologic response to oral polio vaccine in human immunodeficiency virus-infected and uninfected Zimbabwean children.
Gnanashanmugam D; Troy SB; Musingwini G; Huang C; Halpern MS; Stranix-Chibanda L; Shetty AK; Kouiavskaia D; Nathoo K; Chumakov K; Maldonado YA
Pediatr Infect Dis J; 2012 Feb; 31(2):176-80. PubMed ID: 22146742
[TBL] [Abstract][Full Text] [Related]
2. Vaccine poliovirus shedding and immune response to oral polio vaccine in HIV-infected and -uninfected Zimbabwean infants.
Troy SB; Musingwini G; Halpern MS; Huang C; Stranix-Chibanda L; Kouiavskaia D; Shetty AK; Chumakov K; Nathoo K; Maldonado YA
J Infect Dis; 2013 Aug; 208(4):672-8. PubMed ID: 23661792
[TBL] [Abstract][Full Text] [Related]
3. Detection of immunoglobulin G levels produced by oral polio vaccine in HIV infected children in Jos, Plateau State, Nigeria.
Lengkat FA; Chukwudozie OS; Vincent OO; James DM; Amina HG; Kenneth O
Pan Afr Med J; 2019; 34():183. PubMed ID: 32158512
[TBL] [Abstract][Full Text] [Related]
4. Anomalous observations on IPV and OPV vaccination.
John TJ
Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
[TBL] [Abstract][Full Text] [Related]
6. Pediatric HIV Infection and Decreased Prevalence of OPV Point Mutations Linked to Vaccine-associated Paralytic Poliomyelitis.
Halpern MS; Altamirano J; Maldonado Y
Clin Infect Dis; 2018 Oct; 67(suppl_1):S78-S84. PubMed ID: 30376083
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants.
Asturias EJ; Dueger EL; Omer SB; Melville A; Nates SV; Laassri M; Chumakov K; Halsey NA
J Infect Dis; 2007 Sep; 196(5):692-8. PubMed ID: 17674310
[TBL] [Abstract][Full Text] [Related]
8. Immune responses to oral poliovirus vaccine in HIV-exposed uninfected Zimbabwean infants.
Church JA; Rukobo S; Govha M; Carmolli MP; Diehl SA; Chasekwa B; Ntozini R; Mutasa K; Humphrey JH; Kirkpatrick BD; Prendergast AJ
Hum Vaccin Immunother; 2017 Nov; 13(11):2543-2547. PubMed ID: 28857649
[TBL] [Abstract][Full Text] [Related]
9. A survey for neutralizing antibodies to the three types of poliovirus among children in Maiduguri, Nigeria.
Baba MM; Haruna BA; Ogunmola O; Ambe JP; Shidali NN; Oderinde B; Marcello A; Talle M
J Med Virol; 2012 Apr; 84(4):691-6. PubMed ID: 22337311
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria.
Giwa FJ; Olayinka AT; Ogunshola FT
Vaccine; 2012 Nov; 30(48):6759-65. PubMed ID: 23000220
[TBL] [Abstract][Full Text] [Related]
11. Oral iodine supplementation does not reduce neutralizing antibody responses to oral poliovirus vaccine.
Taffs RE; Enterline JC; Rusmil K; Muhilal ; Suwardi SS; Rustama D; Djatnika ; Cobra C; Semba RD; Cohen N; Asher DM
Bull World Health Organ; 1999; 77(6):484-91. PubMed ID: 10427933
[TBL] [Abstract][Full Text] [Related]
12. Shedding of Oral Poliovirus Vaccine (OPV) by HIV-Infected and -Uninfected Mothers of OPV-Vaccinated Zimbabwean Infants.
Holubar M; Troy SB; Nathoo K; Stranix-Chibanda L; Musingwini G; Srinivas N; Huang C; Junn A; Halpern MS; Maldonado YA
J Pediatric Infect Dis Soc; 2017 Mar; 6(1):105-108. PubMed ID: 26759497
[TBL] [Abstract][Full Text] [Related]
13. Asymptomatic wild-type poliovirus infection in India among children with previous oral poliovirus vaccination.
Grassly NC; Jafari H; Bahl S; Durrani S; Wenger J; Sutter RW; Bruce Aylward R
J Infect Dis; 2010 May; 201(10):1535-43. PubMed ID: 20367459
[TBL] [Abstract][Full Text] [Related]
14. Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines.
Steele AD; De Vos B; Tumbo J; Reynders J; Scholtz F; Bos P; de Beer MC; Van der Merwe CF; Delem A
Vaccine; 2010 Sep; 28(39):6542-8. PubMed ID: 18786585
[TBL] [Abstract][Full Text] [Related]
15. Serotype-specific mucosal immune response and subsequent poliovirus replication in vaccinated children.
Samoilovich E; Roivainen M; Titov LP; Hovi T
J Med Virol; 2003 Oct; 71(2):274-80. PubMed ID: 12938203
[TBL] [Abstract][Full Text] [Related]
16. Reduced Poliovirus vaccine neutralising-antibody titres in infants with maternal HIV-exposure.
Sanz-Ramos M; Manno D; Kapambwe M; Ndumba I; Musonda KG; Bates M; Chibumbya J; Siame J; Monze M; Filteau S; Gompels UA;
Vaccine; 2013 Apr; 31(16):2042-9. PubMed ID: 23474309
[TBL] [Abstract][Full Text] [Related]
17. Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel.
Swartz TA; Green MS; Handscher R; Sofer D; Cohen-Dar M; Shohat T; Habib S; Barak E; Dror Z; Somekh E; Peled-Leviathan T; Yulzari R; Libling A; Mendelson E; Shulman LM
Vaccine; 2008 Feb; 26(8):1083-90. PubMed ID: 18241962
[TBL] [Abstract][Full Text] [Related]
18. Population immunity to polioviruses among preschool children from four urban underserved low income communities, United States, 1997-2001.
Prevots DR; Pascual FB; Angellili ML; Brayden R; Irigoyen M; Larussa P; Sawyer M; Baughman AL; Pallansch MA
Pediatr Infect Dis J; 2004 Dec; 23(12):1130-6. PubMed ID: 15626951
[TBL] [Abstract][Full Text] [Related]
19. Oral poliovaccine: will it help eradicate polio or cause the next epidemic?
Shulman LM; Manor Y; Sofer D; Swartz T; Mendelson E
Isr Med Assoc J; 2006 May; 8(5):312-5. PubMed ID: 16805227
[TBL] [Abstract][Full Text] [Related]
20. The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.
Băicuş A; Persu A; Combiescu M; Aubert-Combiescu A
Roum Arch Microbiol Immunol; 2007; 66(1-2):44-50. PubMed ID: 18928063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
